The zipa biotech building the great health services platform of the industrial chain, a high-tech enterprise, a team of professionals, and the great health services platform of the industrial chain, led by a core team of prof. Yoon seon ping, established the zipa biotechnology company, a high-tech enterprise that combines genetic technology development, market applications, health management and integration. It aims to create an accurate, integrated, systematic, individualized, branded, industry-wide health service platform. Focusing on customer experience, keeping pace with market demand, and developing multiple services, zippa biology adheres to the core concept of "technology as a social development" and remains based on client experience and market demand as a research and development orientation. Services such as screening for diseases, genetic testing of children's talents, screening of children's health, guidance on safe medicine, accurate prevention, and online consultations are carried out on the basis of the needs of human health, so that biotechnology actually enters the country's home for the benefit of the general public. The data from the cancer centre show that every year there are more than 3. 5 million new cases of cancer, more than 2 million deaths, and lung, breast and stomach cancer are common. Cancer control is difficult and burdened, and has become one of the major public health problems that seriously endangers human health. Studies show that our overall cancer survival rate is around 30 per cent for five years and that there is still a significant gap in the more developed countries。